These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. H2-receptor antagonists in perspective. Malagelada JR, Cortot A. Mayo Clin Proc; 1978 Mar 30; 53(3):184-90. PubMed ID: 24155 [Abstract] [Full Text] [Related]
12. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Campoli-Richards DM, Clissold SP. Drugs; 1986 Sep 30; 32(3):197-221. PubMed ID: 2875864 [Abstract] [Full Text] [Related]
13. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. Lambers CB, Lind T, Moberg S, Jansen JB, Olbe L. N Engl J Med; 1984 Mar 22; 310(12):758-61. PubMed ID: 6142418 [Abstract] [Full Text] [Related]
14. [25 years of gastric acid blockers]. Lamers CB. Ned Tijdschr Geneeskd; 1999 Dec 11; 143(50):2501-4. PubMed ID: 10627749 [Abstract] [Full Text] [Related]
15. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists]. Lamers CB. Tijdschr Gastroenterol; 1977 Dec 11; 20(6):385-93. PubMed ID: 614726 [No Abstract] [Full Text] [Related]